Trinity Biotech (TRIB) Free Cash Flow (2009 - 2024)

Trinity Biotech has disclosed Free Cash Flow across 6 years of filings, most recently posting $3.7 million for Q4 2024.

• Free Cash Flow for Q4 2024 came in at $3.7 million, up 567.86% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.7 million (up 2189.39% YoY), and the FY2025 annual result was -$5.7 million, down 23.39% from the prior year.
• Free Cash Flow came in at $3.7 million for Q4 2024 at Trinity Biotech, up from -$3.9 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $4.5 million in Q4 2021 to a low of -$7.1 million in Q2 2023.
• The 4-year median for Free Cash Flow is $64194.5 (2021), against an average of $78127.7.
• Across the five-year window, Free Cash Flow sank 4985201.4% in 2023 and jumped 567.86% in 2024, its largest moves.
• Trinity Biotech's Free Cash Flow stood at $4.5 million in 2021, then plunged by 38.35% to $2.8 million in 2022, then tumbled by 79.72% to $560000.0 in 2023, then surged by 567.86% to $3.7 million in 2024.
• The last three Free Cash Flow figures came in at $3.7 million (Q4 2024), -$3.9 million (Q2 2024), and -$3317.0 (Q1 2024), per Business Quant data.